| scholarly article | Q13442814 |
| P50 | author | Jeffrey Shabanowitz | Q28219914 |
| John Lippolis | Q57437883 | ||
| P2093 | author name string | Jarrod A Marto | |
| Donald F Hunt | |||
| Forest M White | |||
| Timothy N J Bullock | |||
| Victor H Engelhard | |||
| Chance J Luckey | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5089-5097 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets | |
| P478 | volume | 169 |
| Q34413009 | A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 2-model applications |
| Q43277065 | Anomalous immunogenic properties of serine proteases |
| Q21203715 | AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data |
| Q57804816 | Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes |
| Q28742682 | Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome |
| Q37281369 | Class II major histocompatibility complex mutant mice to study the germ-line bias of T-cell antigen receptors |
| Q34978613 | Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires |
| Q36186533 | Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases? |
| Q36305321 | Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT |
| Q33393949 | Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research |
| Q59337036 | Footprints of antigen processing boost MHC class II natural ligand predictions |
| Q34338884 | For many but not for all: how the conformational flexibility of the peptide/MHCII complex shapes epitope selection |
| Q36271068 | Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization |
| Q38825612 | High-resolution analysis of the murine MHC class II immunopeptidome |
| Q51556710 | Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma. |
| Q92463453 | Identification of antigens presented by MHC for vaccines against tuberculosis |
| Q30437344 | Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy |
| Q49586408 | Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis |
| Q28238379 | Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response |
| Q30309863 | Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire |
| Q41982582 | Lymphomas can develop from B cells chronically helped by idiotype-specific T cells |
| Q36386903 | Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients |
| Q39474621 | Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells |
| Q44419639 | Microcapillary liquid chromatography/tandem mass spectrometry using alkaline pH mobile phases and positive ion detection |
| Q42651261 | N-terminal flanking residues of a diabetes-associated GAD65 determinant are necessary for activation of antigen-specific T cells in diabetes-resistant mice |
| Q42004430 | Peptide length significantly influences in vitro affinity for MHC class II molecules |
| Q34616781 | Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis |
| Q37360659 | Peptides presented in vivo by HLA-DR in thyroid autoimmunity. |
| Q39175672 | Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing. |
| Q55067919 | Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility. |
| Q38121075 | Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough. |
| Q40151915 | Reconstruction of a pathway of antigen processing and class II MHC peptide capture. |
| Q36778316 | Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity |
| Q33700807 | T cell recognition of naturally presented epitopes of self-heat shock protein 70. |
| Q30444065 | The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes |
| Q35821240 | The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules |
| Q35903181 | The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection |
| Q37939072 | Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools. |
| Q37809187 | Utility, limitations, and promise of proteomics in animal science |
Search more.